SSTR2 and digestive system neuroendocrine tumor, grade 1/2: We also demonstrate the potential of SSTR2 expression for prognosis and application with 68Ga-DOTA-peptide scanning, akin to the application of this imaging technique in gastrointestinal NETs and prostate, breast, and colorectal cancers7,29,30.